A significant breakthrough in cancer study is occurring with the use of VHH fragments to re-engage mutated p53. This essential tumor protector protein is frequently disabled in various kinds of malignancies, leading https://bookmarklinkz.com/story21858523/nanobodies-reactivate-tumor-suppressor-p53-a-promising-pathway-for-tumor-treatment